{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:48Z","timestamp":1783350948975,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.avsg.2026.04.031","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:06:14Z","timestamp":1778108774000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A Systematic Review and Study-Level Meta-Analysis Investigating the Association Between Pre-endovascular Intervention C-Reactive Protein Levels and Femoropopliteal Artery Restenosis"],"prefix":"10.1016","volume":"130","author":[{"given":"Hermann","family":"Pasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Joseph","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"Colleran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-1934","authenticated-orcid":false,"given":"Himanshu","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2026.04.031_bib1","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.04.031_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2026.04.031_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014024","article-title":"Femoropopliteal endovascular intervention: a review of the current landscape","volume":"18","author":"Tannu","year":"2025","journal-title":"Circ Cardiovasc interv"},{"key":"10.1016\/j.avsg.2026.04.031_bib4","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.4244\/EIJ-D-24-00037","article-title":"Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy","volume":"20","author":"Yoon","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.avsg.2026.04.031_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/15266028231202709","article-title":"Systematic review and meta-analysis of clinical outcomes after endovascular treatment in patients with femoropopliteal lesions greater than 50 mm","volume":"32","author":"Dubosq-Lebaz","year":"2025","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2026.04.031_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jvs.2025.04.041","article-title":"Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: focused update","volume":"82","author":"Conte","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/15266028231186717","article-title":"Factors associated with early and late restenosis following drug-coated balloon treatment for patients with femoropopliteal lesions","volume":"32","author":"Toyoshima","year":"2025","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2026.04.031_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcin.2014.01.168","article-title":"Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery","volume":"7","author":"Iida","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2026.04.031_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.avsg.2025.06.027","article-title":"The aggregate index of systemic inflammation: a novel inflammatory marker for predicting restenosis risk in superficial femoral artery lesions after endovascular treatment","volume":"120","author":"Erdogan","year":"2025","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.2251011809","article-title":"Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis","volume":"225","author":"Schillinger","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2026.04.031_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.avsg.2021.09.030","article-title":"C-reactive protein, free fatty acid, and uric acid as predictors of adverse events after endovascular revascularization of arterial femoropopliteal occlusion lesions","volume":"81","author":"Di","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1515\/cclm-2023-0086","article-title":"Why C-reactive protein is one of the most requested tests in clinical laboratories?","volume":"61","author":"Plebani","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib13","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.avsg.2026.04.031_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70757","article-title":"Pre-percutaneous coronary intervention C-reactive protein levels and In-Stent restenosis: a systematic review and meta-analysis","volume":"8","author":"Rai","year":"2025","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.avsg.2026.04.031_bib15","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.avsg.2026.04.031_bib16","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.avsg.2026.04.031_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.avsg.2026.04.031_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin trials"},{"key":"10.1016\/j.avsg.2026.04.031_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2026.04.031_bib20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.avsg.2026.04.031_bib21","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.avsg.2026.04.031_bib22","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.ATV.17.11.3208","article-title":"Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty","volume":"17","author":"Tschopl","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2026.04.031_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/152660280100800509","article-title":"Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation","volume":"8","author":"Schillinger","year":"2001","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2026.04.031_bib24","first-page":"266","article-title":"Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions","volume":"21","author":"Shammas","year":"2009","journal-title":"The J invasive Cardiol"},{"key":"10.1016\/j.avsg.2026.04.031_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejvs.2011.11.025","article-title":"Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions","volume":"43","author":"Lida","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.avsg.2012.02.027","article-title":"Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease","volume":"27","author":"Bleda","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.avsg.2014.12.006","article-title":"Interleukins and inflammatory markers in in-stent restenosis after femoral percutaneous transluminal angioplasty","volume":"29","author":"Araujo","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.avsg.2017.11.064","article-title":"The role of interleukins and inflammatory markers in the early restenosis of covered stents in the femoropopliteal arterial segment","volume":"50","author":"Guimaraes","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/08941939.2019.1690600","article-title":"Clinical significance of Endothelin-1 and C reaction protein in restenosis after the intervention of lower extremity arteriosclerosis obliterans","volume":"34","author":"Lian","year":"2021","journal-title":"J Invest Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12928-020-00691-1","article-title":"A model for predicting the time of early symptomatic restenosis after infrapopliteal angioplasty in patients with critical limb ischemia","volume":"36","author":"Yanagiuchi","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.avsg.2026.04.031_bib31","article-title":"Neutrophil-to-Lymphocyte ratio predicts restenosis after drug-coated balloon therapy for femoropopliteal artery lesions: a retrospective study","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib32","article-title":"The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis","volume":"9","author":"Yang","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib33","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1532\/hsf.5303","article-title":"Systemic immune-inflammation index predicts restenosis after interventions for lower extremity arteriosclerosis obliterans","volume":"26","author":"Tian","year":"2023","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.avsg.2026.04.031_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/DMSO.S496360","article-title":"Relationship between serum HMGB1 and RAGE levels and restenosis in type 2 diabetes mellitus patients complicated with lower extremity vascular disease: a retrospective study","volume":"18","author":"Jia","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.avsg.2026.04.031_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvs.2021.02.026","article-title":"A systematic review and meta-analysis on the association between C-reactive protein levels and adverse limb events after revascularization in patients with peripheral arterial disease","volume":"74","author":"Di","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib36","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","article-title":"Morphological predictors of restenosis after coronary stenting in humans","volume":"105","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.04.031_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.CIR.94.1.35","article-title":"Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study","volume":"94","author":"Mintz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.04.031_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jvs.2005.03.060","article-title":"C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events","volume":"42","author":"Vainas","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.04.031_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib40","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.04.031_bib41","doi-asserted-by":"crossref","first-page":"61F","DOI":"10.1016\/j.amjcard.2005.07.013","article-title":"Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial","volume":"96","author":"Nissen","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2026.04.031_bib42","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the FOURIER trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.04.031_bib44","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib45","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.04.031_bib46","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626002694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626002694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:36:45Z","timestamp":1783348605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509626002694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S0890509626002694"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.04.031","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review and Study-Level Meta-Analysis Investigating the Association Between Pre-endovascular Intervention C-Reactive Protein Levels and Femoropopliteal Artery Restenosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}